Literature DB >> 9915800

Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human dna polymerase alpha/primase.

K L Conger1, J S Liu, S R Kuo, L T Chow, T S Wang.   

Abstract

Papovaviruses are valuable models for the study of DNA replication in higher eukaryotic organisms, as they depend on host factors for replication of their DNA. In this study we investigate the interactions between the human papillomavirus type 11 (HPV-11) origin recognition and initiator protein E1 and human polymerase alpha/primase (pol alpha/primase) subunits. By using a variety of physical assays, we show that both 180- (p180) and 70-kDa (p70) subunits of pol alpha/primase interact with HPV-11 E1. The interactions of E1 with p180 and p70 are functionally different in cell-free replication of an HPV-11 origin-containing plasmid. Exogenously added p180 inhibits both E2-dependent and E2-independent cell-free replication of HPV-11, whereas p70 inhibits E2-dependent but stimulates E2-independent replication. Our experiments indicate that p70 does not physically interact with E2 and suggest that it may compete with E2 for binding to E1. A model of how E2 and p70 sequentially interact with E1 during initiation of viral DNA replication is proposed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915800     DOI: 10.1074/jbc.274.5.2696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex.

Authors:  Eric J Enemark; Arne Stenlund; Leemor Joshua-Tor
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

2.  Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide.

Authors:  Michaël Lehoux; Amélie Fradet-Turcotte; Mathieu Lussier-Price; James G Omichinski; Jacques Archambault
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

3.  Surface mutagenesis of the bovine papillomavirus E1 DNA binding domain reveals residues required for multiple functions related to DNA replication.

Authors:  Stephen Schuck; Arne Stenlund
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  Nucleocytoplasmic shuttling of bovine papillomavirus E1 helicase downregulates viral DNA replication in S phase.

Authors:  Chiung-Yueh Hsu; Francisca Mechali; Catherine Bonne-Andrea
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

5.  Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes.

Authors:  Alexandra Côté-Martin; Cary Moody; Amélie Fradet-Turcotte; Claudia M D'Abramo; Michaël Lehoux; Simon Joubert; Guy G Poirier; Benoit Coulombe; Laimonis A Laimins; Jacques Archambault
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 6.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

7.  mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

Authors:  Wentao Deng; Ge Jin; Biing-Yuan Lin; Brian A Van Tine; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 8.  The E1 proteins.

Authors:  Monika Bergvall; Thomas Melendy; Jacques Archambault
Journal:  Virology       Date:  2013-09-10       Impact factor: 3.616

9.  E1-mediated recruitment of a UAF1-USP deubiquitinase complex facilitates human papillomavirus DNA replication.

Authors:  Michaël Lehoux; David Gagnon; Jacques Archambault
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

10.  Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.

Authors:  Amélie Fradet-Turcotte; Karine Brault; Steve Titolo; Peter M Howley; Jacques Archambault
Journal:  Virology       Date:  2009-12-20       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.